Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Incidental Resolution of Dopamine Agonist Induced Impulse Control Disorder with GLP-1 Receptor Agonist.

Movement disorders clinical practice·2026
Same author

Sexual Function After Prolapse Repair and Retropubic Versus Single-incision Sling.

Urogynecology (Philadelphia, Pa.)·2026
Same author

COVID-19 outcomes and persistent symptoms in patients with hypertrophic cardiomyopathy: association with pre-existing cardiovascular magnetic resonance phenotype.

Heart (British Cardiac Society)·2026
Same author

The burden of heart failure in the United States: Medical costs and health-related quality of life.

Journal of managed care & specialty pharmacy·2026
Same author

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

JAMA·2026
Same author

Prevalence and mortality rate of heart failure across demographic groups in the United States: 2001-2020.

American heart journal plus : cardiology research and practice·2025
Same journal

Vaginal Estrogen: Pearls for the Practitioner <i>A Practical Review of Evidence, Guidelines, and Prescribing Strategies for Genitourinary Syndrome of Menopause</i>.

Journal of women's health (2002)·2026
Same journal

Dysglycemia and Adverse Pregnancy Outcomes Among Individuals with Polycystic Ovary Syndrome.

Journal of women's health (2002)·2026
Same journal

Peer, Social, and Structural Influences on Hormone Therapy Use in Menopause: A U.S. Population Survey.

Journal of women's health (2002)·2026
Same journal

Patterns of Antibiotic Utilization and Bacterial Susceptibility of Prenatal Urinary Tract Infections.

Journal of women's health (2002)·2026
Same journal

Directory of Internal Medicine Residency and Fellowship Programs in Women's Health, 2025.

Journal of women's health (2002)·2026
Same journal

Reassessing Use of Depot Medroxyprogesterone Acetate in Select Groups of Women: Applying the 2024 U.S. Centers for Disease Control and Prevention Medical Eligibility Criteria for Contraceptive Use Guidelines.

Journal of women's health (2002)·2026
查看所有相关文章

相关实验视频

Updated: Sep 13, 2025

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
14:13

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory

Published on: January 1, 2018

13.3K

局部雌激素粘附:一个前性的试点研究.

Feven W Getaneh1, Jon F Pennycuff2, Hannah Kelly3

  • 1Department of Obstetrics and Gynecology, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.

Journal of women's health (2002)
|July 30, 2025
PubMed
概括
此摘要是机器生成的。

局部雌激素治疗 (LET) 可以改善阴道和盆地症状. 医疗保健提供者可以解决坚持治疗的挑战,包括成本和副作用,以提高治疗的持续性.

关键词:
这是一个高潮期的高潮期.雌激素替代药物可以替代雌激素.更年期 绝经 更年期骨盆底部疾病 骨盆底部疾病治疗的坚持 治疗的坚持

更多相关视频

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K
Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

13.5K

相关实验视频

Last Updated: Sep 13, 2025

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory
14:13

Detecting Estrogenic Ligands in Personal Care Products using a Yeast Estrogen Screen Optimized for the Undergraduate Teaching Laboratory

Published on: January 1, 2018

13.3K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.3K
Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats
09:07

Protocol for Studying Extinction of Conditioned Fear in Naturally Cycling Female Rats

Published on: February 23, 2015

13.5K

科学领域:

  • 妇科 妇科医生 妇科
  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科
  • 妇女健康 妇女健康

背景情况:

  • 局部雌激素治疗 (LET) 对各种妇科和泌尿病的疾病提供了显著的益处.
  • 坚持和停止LET治疗的原因尚不清楚,这会影响长期治疗的有效性.

研究的目的:

  • 评估局部雌激素治疗 (LET) 的填充和延续率.
  • 在成年女性中确定与不填充或停止LET相关的因素.

主要方法:

  • 一项涉及155名成年女性的前性观察性研究,新处方LET.
  • 参与者在基线和3个月,6个月和12个月的间隔内完成了验证的问卷 (PFDI-20,DIVA).
  • 停止服用LET的参与者收集了停止服用的原因.

主要成果:

  • 高初始处方填充率 (94%) 和良好的继续率在3 (78%),6 (90%) 和12个月 (79%).
  • 在12个月的研究期间,观察到随访的显著损失 (60%).
  • 不开始使用LET的主要原因包括成本 (33%) 和副作用问题 (22%);停止使用的原因是混乱 (19%) 和副作用 (16%).
  • 使用LET与改善的盆底和阴道症状有关,不管是否继续使用.

结论:

  • 局部雌激素治疗在改善盆底和阴道症状方面表现出有效性,可持续长达12个月.
  • 随访的高损失对LET遵守的前性评估构成了挑战.
  • 解决成本,杂乱和副作用等障碍,可能有助于改善LET的坚持和患者的治疗结果.